Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
ZAUG: Innovator's Defined Outcome ETF for Buffered Equity Exposure

ZAUG: Innovator's Defined Outcome ETF for Buffered Equity Exposure

Key Takeaways

  • ZAUG is an actively managed defined outcome exchange-traded fund (ETF) launched by Innovator Capital Management in July 2024.
  • The fund seeks to track the price return of the SPDR S&P 500 ETF Trust (SPY) up to a predetermined cap while offering a 100% downside buffer over a one-year outcome period, before fees and expenses.
  • It achieves its outcome primarily through FLexible EXchange (FLEX) Options, rather than by holding the underlying stocks directly.
  • The ETF carries a 0.79% expense ratio and does not pay a regular dividend.
  • The 100% buffer and upside cap are only intended to apply to investors who hold shares for the entire outcome period.

What ZAUG Is All About

The Innovator Equity Defined Protection ETF – 1 Yr August, trading under the ticker ZAUG, is a defined outcome ETF built for investors seeking large-cap U.S. equity exposure with an added layer of downside protection. Rather than simply mirroring the S&P 500, the fund combines equity participation with an options structure that targets a cushion against losses over a set one-year window while limiting the upside that can be captured. This approach appeals to those who prefer a more measured way to stay invested in the market.

Fund Overview and Structure

ZAUG comes from Innovator Capital Management, the firm recognized for developing defined outcome ETFs in the U.S. It launched on July 31, 2024, and trades on the Cboe BZX exchange, falling into the Morningstar Defined Outcome category. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry.

The objective is clear yet structured: ZAUG aims to match the price return of the SPDR S&P 500 ETF Trust (SPY), which tracks the S&P 500 Index, up to a set upside cap. At the same time, it targets a 100% downside buffer against losses in the underlying ETF over the one-year outcome period, before fees and expenses. This is an actively managed fund, with results generated through a derivatives portfolio rather than direct stock holdings.

To deliver these outcomes, ZAUG puts at least 80% of its net assets into FLexible EXchange Options (FLEX Options) linked to the underlying ETF. Holdings tend to be concentrated, with the largest position often the Vanguard S&P 500 ETF (VOO) plus a limited set of FLEX option contracts that establish the cap and buffer. The options-based design means the fund typically maintains only a small number of positions. It is non-diversified and carries a 0.79% expense ratio.

Outcome periods run for about one year, starting in August and resetting annually. The cap and buffer are determined at the beginning of each period based on current market conditions and can change yearly. Full downside protection and the upside cap are intended only for investors who hold through the entire outcome period.

What Draws Investors to ZAUG

ZAUG stands out for its distinctive risk profile, offering equity-like gains up to a cap alongside a stated goal of shielding against 100% of the reference asset’s losses over the defined window. For investors concerned about downturns yet still interested in large-cap U.S. equity exposure, this buffered strategy can act as a portfolio component that helps moderate volatility.

Sector exposure aligns with the broad S&P 500, with significant weight in large-cap technology, financial services, healthcare, and consumer discretionary areas. This provides diversified market access while the options overlay shapes the risk-reward balance. The defined outcome framework also brings clarity, as investors know the maximum upside and intended downside protection at the start of each period, which can aid planning compared with an unhedged equity fund.

Key Risks and Considerations

Several factors warrant attention before considering ZAUG. The upside cap limits participation in gains beyond a certain point, so sharp S&P 500 rallies would leave ZAUG trailing a standard index fund. The downside buffer is not assured; the fund seeks to provide it, but success is not guaranteed, and protection applies only to those holding shares for the full outcome period. Mid-period purchases or sales produce different results than those outlined at the start.

Other points include the 0.79% expense ratio, higher than many plain index ETFs, and the lack of regular dividend income. The concentrated, derivatives-focused holdings introduce risks tied to FLEX Options pricing and liquidity. As a non-diversified fund with heavy large-cap U.S. equity concentration, ZAUG remains exposed to broader equity market movements despite the buffer design.

Researching Options with Tickeron’s AI Screener

I find Tickeron’s AI Screener helpful when evaluating defined outcome ETFs like ZAUG or comparing them to broader equity strategies. It lets users apply technical indicators, fundamentals, volatility measures, trends, AI signals, industry filters, and price patterns to screen thousands of securities and identify ideas that fit specific approaches. This makes it a practical resource for refining research on structured products or equity exposure.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ZAUG

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


ZAUG in downward trend: price dove below 50-day moving average on November 13, 2026

ZAUG moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 5 of 9 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 56%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZAUG as a result. In 14 of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 40%.

The Moving Average Convergence Divergence Histogram (MACD) for ZAUG turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 21 similar instances when the indicator turned negative. In 6 of the 21 cases the stock turned lower in the days that followed. This puts the odds of success at 29%.

The 10-day moving average for ZAUG crossed bearishly below the 50-day moving average on November 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 1 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 33%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZAUG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 27%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ZAUG's RSI Indicator exited the oversold zone, 3 of 6 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +0.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZAUG advanced for three days, in 59 of 160 cases, the price rose further within the following month. The odds of a continued upward trend are 37%.

ZAUG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 60 of 191 cases where ZAUG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 31%.

Industry description

The investment seeks to provide investors with returns that match the return of the Underlying ETF, up to the upside cap of 8.37% (prior to taking into account management fees and other fees) while providing a buffer against 100% of Underlying ETF losses (prior to taking into account management fees and other fees), over the period from August 1, 2026 to July 31, 2027. The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in FLexible EXchange® Options (“FLEX Options”) that reference the SPDR® S&P 500® ETF Trust (the “Underlying ETF”). The fund is non-diversified.
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.